Biolase Price to Book Ratio 2010-2023 | BIOL
Historical price to book ratio values for Biolase (BIOL) over the last 10 years. The current price to book ratio for Biolase as of April 23, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Biolase Price/Book Ratio Historical Data |
Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
2024-04-23 |
0.15 |
|
0.26 |
2023-12-31 |
1.12 |
$0.57 |
1.96 |
2023-09-30 |
1.86 |
$2.60 |
0.72 |
2023-06-30 |
7.07 |
$7.20 |
0.98 |
2023-03-31 |
28.12 |
$30.99 |
0.91 |
2022-12-31 |
65.00 |
$63.49 |
1.02 |
2022-09-30 |
243.00 |
$194.04 |
1.25 |
2022-06-30 |
458.00 |
$315.32 |
1.45 |
2022-03-31 |
883.00 |
$333.66 |
2.65 |
2021-12-31 |
975.00 |
$410.09 |
2.38 |
2021-09-30 |
1598.25 |
$494.56 |
3.23 |
2021-06-30 |
1745.25 |
$549.90 |
3.17 |
2021-03-31 |
2107.25 |
$560.91 |
3.76 |
2020-12-31 |
1041.75 |
$256.70 |
4.06 |
2020-09-30 |
687.75 |
$372.34 |
1.85 |
2020-06-30 |
1157.50 |
$65.01 |
17.81 |
2020-03-31 |
937.50 |
$-70.63 |
-13.27 |
2019-12-31 |
1381.75 |
$345.27 |
4.00 |
2019-09-30 |
2350.00 |
$-121.39 |
-19.36 |
2019-06-30 |
3675.00 |
$433.55 |
8.48 |
2019-03-31 |
5950.00 |
$818.66 |
7.27 |
2018-12-31 |
2475.00 |
$1,261.72 |
1.96 |
2018-09-30 |
5175.00 |
$1,977.25 |
2.62 |
2018-06-30 |
3025.00 |
$2,474.88 |
1.22 |
2018-03-31 |
5075.00 |
$3,044.66 |
1.67 |
2017-12-31 |
5330.00 |
$3,573.87 |
1.49 |
2017-09-30 |
7535.00 |
$3,480.22 |
2.17 |
2017-06-30 |
12125.00 |
$4,163.10 |
2.91 |
2017-03-31 |
16875.00 |
$3,393.02 |
4.97 |
2016-12-31 |
17500.00 |
$4,082.12 |
4.29 |
2016-09-30 |
21875.00 |
$4,821.21 |
4.54 |
2016-06-30 |
14625.00 |
$4,066.46 |
3.60 |
2016-03-31 |
16375.00 |
$4,633.13 |
3.53 |
2015-12-31 |
10513.75 |
$5,350.73 |
1.96 |
2015-09-30 |
11250.00 |
$5,655.36 |
1.99 |
2015-06-30 |
21750.00 |
$6,671.26 |
3.26 |
2015-03-31 |
25250.00 |
$7,980.67 |
3.16 |
2014-12-31 |
32875.00 |
$9,045.86 |
3.63 |
2014-09-30 |
31125.00 |
$3,156.57 |
9.86 |
2014-06-30 |
27500.00 |
$964.17 |
28.52 |
2014-03-31 |
30125.00 |
$2,991.62 |
10.07 |
2013-12-31 |
35199.01 |
$2,997.07 |
11.74 |
2013-09-30 |
23662.78 |
$3,373.80 |
7.01 |
2013-06-30 |
44085.42 |
$3,142.96 |
14.03 |
2013-03-31 |
48767.33 |
$3,761.48 |
12.96 |
2012-12-31 |
22555.46 |
$4,712.47 |
4.79 |
2012-09-30 |
20623.52 |
$4,020.57 |
5.13 |
2012-06-30 |
23538.70 |
$4,119.56 |
5.71 |
2012-03-31 |
32550.01 |
$4,642.62 |
7.01 |
2011-12-31 |
30714.89 |
$5,043.20 |
6.09 |
2011-09-30 |
35498.97 |
$5,578.29 |
6.36 |
2011-06-30 |
60219.38 |
$5,853.40 |
10.29 |
2011-03-31 |
56491.19 |
$1,833.87 |
30.80 |
2010-12-31 |
20098.72 |
$-1,480.25 |
-13.58 |
2010-09-30 |
13437.43 |
$-1,659.83 |
-8.10 |
2010-06-30 |
17342.33 |
$-612.81 |
-28.30 |
2010-03-31 |
22395.72 |
$1,283.33 |
17.45 |
2009-12-31 |
21936.32 |
$3,773.18 |
5.81 |
2009-09-30 |
25956.06 |
$4,312.29 |
6.02 |
2009-06-30 |
19409.62 |
$3,666.00 |
5.29 |
2009-03-31 |
10279.06 |
$2,304.20 |
4.46 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|